Femme Homme
- | Pays :
- Greece
- | Organes : -
- | Spécialités : -
Extrait
This study will evaluate the efficacy and toxicity of docetaxel, gemcitabine and bevacizumab combination, administered biweekly, as salvage treatment in patients with metastatic and HER2 negative breast cancer.
Critère d'inclusion
- Breast Cancer